Pharmaceutical Ingredients (for Research and Experimental Use)
SUBCLASS
Antidiabetic Ingredients (for Research and Experimental Use)
COUNTRY OF ORIGIN
Japan
APPLICATION
Glibenclamide: A Sulfonylurea ATP-Dependent K+ Channel Antagonist
Glibenclamide belongs to sulfonylurea antidiabetics which increase the release of insulin from pancreatic B-cells. Sulfonylurea antidiabetics inhibit ATP-gated K+ channels and thereby cause depolarization of the B-cell membrane. The depolarization leads to activation of voltage-dependent Ca channels and Ca2+ influx into the B-cell, and eventually increases insulin release. Recently, a combination agent with metformin [M2009] is also used for the treatment of Type 2 diabetes. (The product is for research purpose only.)
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.